Vietnam Manufacturing and Export Processing Holdings Ltd
HKEX:422
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vietnam Manufacturing and Export Processing Holdings Ltd
HKEX:422
|
HK |
|
N
|
Nextage Therapeutics Ltd
TASE:NXTG
|
IL |
Balance Sheet
Balance Sheet Decomposition
Vietnam Manufacturing and Export Processing Holdings Ltd
Vietnam Manufacturing and Export Processing Holdings Ltd
Balance Sheet
Vietnam Manufacturing and Export Processing Holdings Ltd
| Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Cash & Cash Equivalents |
43
|
24
|
47
|
126
|
47
|
89
|
116
|
66
|
55
|
23
|
16
|
21
|
11
|
13
|
29
|
19
|
16
|
11
|
11
|
63
|
63
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
54
|
54
|
|
| Cash Equivalents |
43
|
24
|
47
|
126
|
47
|
89
|
116
|
66
|
55
|
23
|
16
|
21
|
11
|
13
|
29
|
19
|
16
|
11
|
11
|
9
|
8
|
|
| Short-Term Investments |
15
|
14
|
9
|
13
|
81
|
31
|
14
|
48
|
68
|
95
|
102
|
82
|
93
|
89
|
35
|
33
|
33
|
40
|
45
|
37
|
40
|
|
| Total Receivables |
7
|
11
|
10
|
13
|
11
|
19
|
10
|
10
|
15
|
24
|
31
|
29
|
25
|
20
|
22
|
26
|
25
|
26
|
37
|
20
|
18
|
|
| Accounts Receivables |
5
|
6
|
5
|
6
|
7
|
4
|
3
|
4
|
5
|
9
|
15
|
29
|
25
|
20
|
12
|
13
|
12
|
11
|
20
|
10
|
11
|
|
| Other Receivables |
2
|
5
|
5
|
8
|
5
|
15
|
7
|
7
|
10
|
15
|
17
|
0
|
0
|
0
|
10
|
13
|
12
|
15
|
17
|
10
|
7
|
|
| Inventory |
47
|
39
|
35
|
41
|
34
|
34
|
27
|
40
|
32
|
32
|
30
|
21
|
25
|
19
|
25
|
23
|
25
|
29
|
26
|
23
|
22
|
|
| Other Current Assets |
23
|
37
|
24
|
15
|
16
|
3
|
1
|
1
|
1
|
3
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
134
|
124
|
125
|
208
|
189
|
176
|
167
|
165
|
172
|
177
|
182
|
153
|
154
|
141
|
111
|
101
|
99
|
106
|
118
|
98
|
96
|
|
| PP&E Net |
41
|
42
|
41
|
40
|
41
|
39
|
41
|
34
|
29
|
25
|
23
|
18
|
18
|
14
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
|
| PP&E Gross |
41
|
42
|
41
|
40
|
41
|
39
|
41
|
34
|
29
|
25
|
23
|
0
|
0
|
0
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
|
| Accumulated Depreciation |
35
|
41
|
47
|
52
|
54
|
55
|
59
|
61
|
69
|
73
|
0
|
0
|
0
|
0
|
102
|
112
|
114
|
110
|
108
|
99
|
90
|
|
| Intangible Assets |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
5
|
5
|
5
|
5
|
5
|
4
|
|
| Other Long-Term Assets |
4
|
4
|
4
|
4
|
4
|
5
|
1
|
7
|
7
|
7
|
7
|
6
|
6
|
6
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
179
N/A
|
172
-4%
|
171
0%
|
253
+47%
|
236
-7%
|
221
-6%
|
210
-5%
|
207
-1%
|
209
+1%
|
210
+1%
|
212
+1%
|
177
-16%
|
178
+0%
|
162
-9%
|
115
-29%
|
109
-5%
|
107
-2%
|
114
+6%
|
127
+12%
|
106
-16%
|
103
-3%
|
|
| Liabilities | ||||||||||||||||||||||
| Accounts Payable |
26
|
17
|
19
|
28
|
13
|
28
|
24
|
18
|
21
|
16
|
0
|
15
|
16
|
12
|
7
|
7
|
9
|
17
|
26
|
13
|
38
|
|
| Accrued Liabilities |
0
|
0
|
0
|
4
|
2
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
12
|
19
|
17
|
13
|
40
|
8
|
1
|
0
|
0
|
21
|
37
|
25
|
26
|
23
|
19
|
28
|
31
|
36
|
40
|
43
|
34
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
25
|
13
|
12
|
18
|
9
|
15
|
14
|
10
|
16
|
13
|
5
|
1
|
1
|
1
|
7
|
8
|
10
|
8
|
8
|
7
|
6
|
|
| Total Current Liabilities |
62
|
49
|
48
|
63
|
64
|
53
|
42
|
32
|
37
|
49
|
63
|
41
|
43
|
36
|
33
|
44
|
49
|
60
|
74
|
53
|
56
|
|
| Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
63
N/A
|
50
-22%
|
49
-2%
|
63
+30%
|
64
+1%
|
53
-17%
|
42
-21%
|
32
-25%
|
37
+18%
|
49
+32%
|
63
+27%
|
41
-35%
|
43
+6%
|
36
-17%
|
33
-8%
|
45
+35%
|
50
+11%
|
61
+23%
|
76
+25%
|
55
-28%
|
58
+6%
|
|
| Equity | ||||||||||||||||||||||
| Common Stock |
59
|
59
|
59
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
57
|
64
|
65
|
57
|
66
|
66
|
71
|
89
|
84
|
75
|
64
|
135
|
133
|
125
|
4
|
13
|
21
|
26
|
26
|
25
|
29
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
132
|
112
|
112
|
112
|
112
|
112
|
112
|
0
|
0
|
0
|
0
|
112
|
112
|
112
|
112
|
112
|
112
|
112
|
|
| Other Equity |
0
|
1
|
1
|
1
|
8
|
12
|
17
|
26
|
26
|
27
|
0
|
0
|
0
|
0
|
35
|
35
|
35
|
35
|
36
|
37
|
40
|
|
| Total Equity |
116
N/A
|
122
+5%
|
123
+1%
|
190
+54%
|
172
-9%
|
167
-3%
|
168
+0%
|
175
+5%
|
172
-2%
|
161
-6%
|
149
-7%
|
136
-9%
|
135
-1%
|
126
-7%
|
82
-35%
|
65
-21%
|
57
-11%
|
53
-8%
|
51
-3%
|
51
+1%
|
45
-12%
|
|
| Total Liabilities & Equity |
179
N/A
|
172
-4%
|
171
0%
|
253
+47%
|
236
-7%
|
221
-6%
|
210
-5%
|
207
-1%
|
209
+1%
|
210
+1%
|
212
+1%
|
177
-16%
|
178
+0%
|
162
-9%
|
115
-29%
|
109
-5%
|
107
-2%
|
114
+6%
|
127
+12%
|
106
-16%
|
103
-3%
|
|
| Shares Outstanding | ||||||||||||||||||||||
| Common Shares Outstanding |
908
|
908
|
908
|
908
|
908
|
908
|
908
|
908
|
908
|
908
|
908
|
908
|
908
|
908
|
908
|
908
|
908
|
908
|
908
|
908
|
908
|
|